Skip to main content

Table 2 Association between KLK8 and cognitive status (aMCI vs. CU)

From: Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study

  OR 95%CI OR 95%CI
Per 500 pg/ml KLK8 1.113 0.821 1.511 2.683 1.053 6.835
Experimenter 2 vs. 3a     0.031 0.002 0.577
Experimenter 1 vs. 3a     5.916 0.897 39.033
Freezing duration, years     0.927 0.842 1.020
  1. Age and sex are taken into account by matching for them
  2. aMCI amnestic mild cognitive impairment, CU cognitive unimpaired, OR odds ratio, 95%CI 95%-confidence interval, KLK8 kallikrein 8
  3. a We adjusted for experimenter as a proxy for the inter-assay variability